Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Statement of Comprehensive Income

Beginner level

Regeneron Pharmaceuticals Inc., consolidated statement of comprehensive income

US$ in thousands

Microsoft Excel LibreOffice Calc
12 months ended: Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net income 2,115,800  2,444,400  1,198,511  895,522  636,056 
Unrealized gain (loss) on marketable securities 35,900  (7,000) 12,715  (21,412) (43,679)
Unrealized gain (loss) on cash flow hedges (2,500) 700  765  —  — 
Other comprehensive income (loss), net of tax 33,400  (6,300) 13,480  (21,412) (43,679)
Comprehensive income 2,149,200  2,438,100  1,211,991  874,110  592,377 

Based on: 10-K (filing date: 2020-02-07), 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11).

Comprehensive income item Description The company
Net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Regeneron Pharmaceuticals Inc.’s net income increased from 2017 to 2018 but then slightly decreased from 2018 to 2019.
Comprehensive income Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Regeneron Pharmaceuticals Inc.’s comprehensive income increased from 2017 to 2018 but then slightly decreased from 2018 to 2019.